Publications by authors named "Tim Brooks"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

143,930

Total Likes

4,983

Extended Reach

1,858,780

Social Features

405
D
Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025.
Anna Rydlova, Emma Smith, Arabella Stuart, Robin Shattock, Tim Brooks

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023.
Helen Callaby, Kate R Beard, Dominic Wakerley, Mary Alexandra Lake, Jane Osborne, Tim Brooks

Euro Surveill· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of Borrelia burgdorferi sensu lato antibodies in English adult blood donors: A nationwide cross-sectional study, 2021-2022.
Eilish Hart, John Tulloch, Daniel Bailey, Tim Brooks, Heli Harvala

Ticks Tick Borne Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of a Human Case of Francisella tularensis Infection, United Kingdom, 2023.
Ameeka Thompson, Tim Brooks, Catherine Houlihan, Tommy Rampling, Helen Umpleby

Emerg Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assays.
Heidi Hempel, Mark Page, Troy Kemp, Amanda Semper, Tim Brooks

Lancet Microbe· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek Abhishek, Nicholas Peckham, Corinna Pade, Joseph M Gibbons, Lucy Cureton, Tim Brooks

Lancet Rheumatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.
Ana Atti, Ferdinando Insalata, Edward J Carr, Ashley D Otter, Sarah Foulkes, Tim Brooks

J Infect· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
Ashley D Otter, Scott Jones, Bethany Hicks, Daniel Bailey, Helen Callaby, Tim Brooks

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.
Daniel M Altmann, Catherine J Reynolds, George Joy, Ashley D Otter, Joseph M Gibbons, Tim Brooks

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
Martina Milighetti, Yanchun Peng, Cedric Tan, Michal Mark, Gayathri Nageswaran, Tim Brooks

iScience· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.
Ana Atti, Ferdinando Insalata, Edward J Carr, Ashley D Otter, Javier Castillo-Olivares, Tim Brooks

J Infect· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.
Gabriella Captur, James C Moon, Constantin-Cristian Topriceanu, George Joy, Leo Swadling, Tim Brooks

EBioMedicine· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.
Abhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, Áine McKnight, Laura C Coates, Tim Brooks

Lancet Respir Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response.
Ivan Doykov, Tomas Baldwin, Justyna Spiewak, Kimberly C Gilmour, Joseph M Gibbons, Tim Brooks

Cell Rep Methods· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Anaplasma phagocytophilum in questing Ixodes ricinus nymphs across twenty recreational areas in England and Wales.
Sara Gandy, Kayleigh Hansford, Liz McGinley, Benjamin Cull, Rob Smith, Tim Brooks

Ticks Tick Borne Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
Heather Whitaker, Ruby S M Tsang, Elizabeth Button, Nick Andrews, Rachel Byford, Tim Brooks

J Infect· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.
Sarah Wallace, Victoria Hall, Andre Charlett, Peter D Kirwan, Michele Cole, Tim J G Brooks

BMJ Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, Peter Kirwan, Ayoub Saei, Tim Brooks

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
Aneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, Leo Swadling, Gabriele Pollara, Tim Brooks

Cell Rep Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.
Ashley David Otter, Abbie Bown, Silvia D'Arcangelo, Daniel Bailey, Amanda Semper, Tim Brooks

Microbiol Spectr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
Javier Castillo-Olivares, David A Wells, Matteo Ferrari, Andrew C Y Chan, Peter Smith, Tim Brooks

Front Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.
Roanne Keeton, Simone I Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B Tincho, Tim Brooks

Cell Host Microbe· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis